 | • レポートコード：GIR-105X05121 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、診断核医療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。診断核医療の種類別市場規模（Tc-99m、F-18、その他）、用途別市場規模（腫瘍、心臓病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・診断核医療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bracco Imaging、Bayer、Curium Pharmaceuticals、Nordion、Triad Isotopes、Lantheus、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Novartis、SIEMENS、Dongcheng、Navidea ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：Tc-99m、F-18、その他 ・用途別分析2016年-2026年：腫瘍、心臓病、その他 ・診断核医療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・診断核医療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・診断核医療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・診断核医療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・診断核医療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Diagnostic Nuclear Medicines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Diagnostic Nuclear Medicines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Diagnostic Nuclear Medicines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Diagnostic Nuclear Medicines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tc-99m
F-18
Other
Market segment by Application can be divided into
Oncology
Cardiology
Other
The key market players for global Diagnostic Nuclear Medicines market are listed below:
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Diagnostic Nuclear Medicines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diagnostic Nuclear Medicines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tc-99m
1.2.3 F-18
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Diagnostic Nuclear Medicines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Nuclear Medicines Market Size & Forecast
1.4.1 Global Diagnostic Nuclear Medicines Sales in Value (2016-2026))
1.4.2 Global Diagnostic Nuclear Medicines Sales in Volume (2016-2026)
1.4.3 Global Diagnostic Nuclear Medicines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Diagnostic Nuclear Medicines Production Capacity Analysis
1.5.1 Global Diagnostic Nuclear Medicines Total Production Capacity (2016-2026)
1.5.2 Global Diagnostic Nuclear Medicines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diagnostic Nuclear Medicines Market Drivers
1.6.2 Diagnostic Nuclear Medicines Market Restraints
1.6.3 Diagnostic Nuclear Medicines Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Diagnostic Nuclear Medicines Product and Services
2.1.4 Bracco Imaging Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Diagnostic Nuclear Medicines Product and Services
2.2.4 Bayer Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Curium Pharmaceuticals
2.3.1 Curium Pharmaceuticals Details
2.3.2 Curium Pharmaceuticals Major Business
2.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product and Services
2.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Nordion
2.4.1 Nordion Details
2.4.2 Nordion Major Business
2.4.3 Nordion Diagnostic Nuclear Medicines Product and Services
2.4.4 Nordion Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Triad Isotopes
2.5.1 Triad Isotopes Details
2.5.2 Triad Isotopes Major Business
2.5.3 Triad Isotopes Diagnostic Nuclear Medicines Product and Services
2.5.4 Triad Isotopes Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Diagnostic Nuclear Medicines Product and Services
2.6.4 Lantheus Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 GE Healthcare
2.7.1 GE Healthcare Details
2.7.2 GE Healthcare Major Business
2.7.3 GE Healthcare Diagnostic Nuclear Medicines Product and Services
2.7.4 GE Healthcare Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 China Isotope & Radiation
2.8.1 China Isotope & Radiation Details
2.8.2 China Isotope & Radiation Major Business
2.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Product and Services
2.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Jubilant Pharma
2.9.1 Jubilant Pharma Details
2.9.2 Jubilant Pharma Major Business
2.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Product and Services
2.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Diagnostic Nuclear Medicines Product and Services
2.10.4 Eli Lilly Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Diagnostic Nuclear Medicines Product and Services
2.11.4 Novartis Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 SIEMENS
2.12.1 SIEMENS Details
2.12.2 SIEMENS Major Business
2.12.3 SIEMENS Diagnostic Nuclear Medicines Product and Services
2.12.4 SIEMENS Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Dongcheng
2.13.1 Dongcheng Details
2.13.2 Dongcheng Major Business
2.13.3 Dongcheng Diagnostic Nuclear Medicines Product and Services
2.13.4 Dongcheng Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Navidea
2.14.1 Navidea Details
2.14.2 Navidea Major Business
2.14.3 Navidea Diagnostic Nuclear Medicines Product and Services
2.14.4 Navidea Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Diagnostic Nuclear Medicines Sales by Manufacturer
3.1 Global Diagnostic Nuclear Medicines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Diagnostic Nuclear Medicines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Diagnostic Nuclear Medicines
3.4 Market Concentration Rate
3.4.1 Top 3 Diagnostic Nuclear Medicines Manufacturer Market Share
3.4.2 Top 6 Diagnostic Nuclear Medicines Manufacturer Market Share
3.5 Global Diagnostic Nuclear Medicines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Diagnostic Nuclear Medicines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Diagnostic Nuclear Medicines Market Size by Region
4.1.1 Global Diagnostic Nuclear Medicines Sales in Volume by Region (2016-2026)
4.1.2 Global Diagnostic Nuclear Medicines Revenue by Region (2016-2026)
4.2 North America Diagnostic Nuclear Medicines Revenue (2016-2026)
4.3 Europe Diagnostic Nuclear Medicines Revenue (2016-2026)
4.4 Asia-Pacific Diagnostic Nuclear Medicines Revenue (2016-2026)
4.5 South America Diagnostic Nuclear Medicines Revenue (2016-2026)
4.6 Middle East and Africa Diagnostic Nuclear Medicines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Diagnostic Nuclear Medicines Sales in Volume by Type (2016-2026)
5.2 Global Diagnostic Nuclear Medicines Revenue by Type (2016-2026)
5.3 Global Diagnostic Nuclear Medicines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Diagnostic Nuclear Medicines Sales in Volume by Application (2016-2026)
6.2 Global Diagnostic Nuclear Medicines Revenue by Application (2016-2026)
6.3 Global Diagnostic Nuclear Medicines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Diagnostic Nuclear Medicines Sales by Type (2016-2026)
7.2 North America Diagnostic Nuclear Medicines Sales by Application (2016-2026)
7.3 North America Diagnostic Nuclear Medicines Market Size by Country
7.3.1 North America Diagnostic Nuclear Medicines Sales in Volume by Country (2016-2026)
7.3.2 North America Diagnostic Nuclear Medicines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Diagnostic Nuclear Medicines Sales by Type (2016-2026)
8.2 Europe Diagnostic Nuclear Medicines Sales by Application (2016-2026)
8.3 Europe Diagnostic Nuclear Medicines Market Size by Country
8.3.1 Europe Diagnostic Nuclear Medicines Sales in Volume by Country (2016-2026)
8.3.2 Europe Diagnostic Nuclear Medicines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Diagnostic Nuclear Medicines Sales by Type (2016-2026)
9.2 Asia-Pacific Diagnostic Nuclear Medicines Sales by Application (2016-2026)
9.3 Asia-Pacific Diagnostic Nuclear Medicines Market Size by Region
9.3.1 Asia-Pacific Diagnostic Nuclear Medicines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Diagnostic Nuclear Medicines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Diagnostic Nuclear Medicines Sales by Type (2016-2026)
10.2 South America Diagnostic Nuclear Medicines Sales by Application (2016-2026)
10.3 South America Diagnostic Nuclear Medicines Market Size by Country
10.3.1 South America Diagnostic Nuclear Medicines Sales in Volume by Country (2016-2026)
10.3.2 South America Diagnostic Nuclear Medicines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Diagnostic Nuclear Medicines Sales by Type (2016-2026)
11.2 Middle East & Africa Diagnostic Nuclear Medicines Sales by Application (2016-2026)
11.3 Middle East & Africa Diagnostic Nuclear Medicines Market Size by Country
11.3.1 Middle East & Africa Diagnostic Nuclear Medicines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Diagnostic Nuclear Medicines Typical Distributors
12.3 Diagnostic Nuclear Medicines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Diagnostic Nuclear Medicines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Diagnostic Nuclear Medicines Revenue by Application, (USD Million), 2021-2026
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Diagnostic Nuclear Medicines Product and Services
Table 6. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Diagnostic Nuclear Medicines Product and Services
Table 10. Bayer Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Curium Pharmaceuticals Major Business
Table 13. Curium Pharmaceuticals Diagnostic Nuclear Medicines Product and Services
Table 14. Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Nordion Basic Information, Manufacturing Base and Competitors
Table 16. Nordion Major Business
Table 17. Nordion Diagnostic Nuclear Medicines Product and Services
Table 18. Nordion Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 20. Triad Isotopes Major Business
Table 21. Triad Isotopes Diagnostic Nuclear Medicines Product and Services
Table 22. Triad Isotopes Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Lantheus Basic Information, Manufacturing Base and Competitors
Table 24. Lantheus Major Business
Table 25. Lantheus Diagnostic Nuclear Medicines Product and Services
Table 26. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 28. GE Healthcare Major Business
Table 29. GE Healthcare Diagnostic Nuclear Medicines Product and Services
Table 30. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 32. China Isotope & Radiation Major Business
Table 33. China Isotope & Radiation Diagnostic Nuclear Medicines Product and Services
Table 34. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Jubilant Pharma Major Business
Table 37. Jubilant Pharma Diagnostic Nuclear Medicines Product and Services
Table 38. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 40. Eli Lilly Major Business
Table 41. Eli Lilly Diagnostic Nuclear Medicines Product and Services
Table 42. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Major Business
Table 45. Novartis Diagnostic Nuclear Medicines Product and Services
Table 46. Novartis Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 48. SIEMENS Major Business
Table 49. SIEMENS Diagnostic Nuclear Medicines Product and Services
Table 50. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 52. Dongcheng Major Business
Table 53. Dongcheng Diagnostic Nuclear Medicines Product and Services
Table 54. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Navidea Basic Information, Manufacturing Base and Competitors
Table 56. Navidea Major Business
Table 57. Navidea Diagnostic Nuclear Medicines Product and Services
Table 58. Navidea Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Diagnostic Nuclear Medicines Sales by Manufacturer (2019-2021e) & (K Units)
Table 60. Global Diagnostic Nuclear Medicines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Diagnostic Nuclear Medicines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Diagnostic Nuclear Medicines Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Diagnostic Nuclear Medicines Production Site of Key Manufacturer
Table 64. Global Diagnostic Nuclear Medicines Sales by Region (2016-2021e) & (K Units)
Table 65. Global Diagnostic Nuclear Medicines Sales by Region (2021-2026) & (K Units)
Table 66. Global Diagnostic Nuclear Medicines Revenue by Region (2016-2021e) & (USD Million)
Table 67. Global Diagnostic Nuclear Medicines Revenue by Region (2021-2026) & (USD Million)
Table 68. Global Diagnostic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 69. Global Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 70. Global Diagnostic Nuclear Medicines Revenue by Type (2016-2021e) & (USD Million)
Table 71. Global Diagnostic Nuclear Medicines Revenue by Type (2021-2026) & (USD Million)
Table 72. Global Diagnostic Nuclear Medicines Price by Type (2016-2021e) & (USD/Unit)
Table 73. Global Diagnostic Nuclear Medicines Price by Type (2021-2026) & (USD/Unit)
Table 74. Global Diagnostic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 75. Global Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 76. Global Diagnostic Nuclear Medicines Revenue by Application (2016-2021e) & (USD Million)
Table 77. Global Diagnostic Nuclear Medicines Revenue by Application (2021-2026) & (USD Million)
Table 78. Global Diagnostic Nuclear Medicines Price by Application (2016-2021e) & (USD/Unit)
Table 79. Global Diagnostic Nuclear Medicines Price by Application (2021-2026) & (USD/Unit)
Table 80. North America Diagnostic Nuclear Medicines Sales by Country (2016-2021e) & (K Units)
Table 81. North America Diagnostic Nuclear Medicines Sales by Country (2021-2026) & (K Units)
Table 82. North America Diagnostic Nuclear Medicines Revenue by Country (2016-2021e) & (USD Million)
Table 83. North America Diagnostic Nuclear Medicines Revenue by Country (2021-2026) & (USD Million)
Table 84. North America Diagnostic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 85. North America Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 86. North America Diagnostic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 87. North America Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 88. Europe Diagnostic Nuclear Medicines Sales by Country (2016-2021e) & (K Units)
Table 89. Europe Diagnostic Nuclear Medicines Sales by Country (2021-2026) & (K Units)
Table 90. Europe Diagnostic Nuclear Medicines Revenue by Country (2016-2021e) & (USD Million)
Table 91. Europe Diagnostic Nuclear Medicines Revenue by Country (2021-2026) & (USD Million)
Table 92. Europe Diagnostic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 93. Europe Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 94. Europe Diagnostic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 95. Europe Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 96. Asia-Pacific Diagnostic Nuclear Medicines Sales by Region (2016-2021e) & (K Units)
Table 97. Asia-Pacific Diagnostic Nuclear Medicines Sales by Region (2021-2026) & (K Units)
Table 98. Asia-Pacific Diagnostic Nuclear Medicines Revenue by Region (2016-2021e) & (USD Million)
Table 99. Asia-Pacific Diagnostic Nuclear Medicines Revenue by Region (2021-2026) & (USD Million)
Table 100. Asia-Pacific Diagnostic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 101. Asia-Pacific Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 102. Asia-Pacific Diagnostic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 103. Asia-Pacific Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 104. South America Diagnostic Nuclear Medicines Sales by Country (2016-2021e) & (K Units)
Table 105. South America Diagnostic Nuclear Medicines Sales by Country (2021-2026) & (K Units)
Table 106. South America Diagnostic Nuclear Medicines Revenue by Country (2016-2021e) & (USD Million)
Table 107. South America Diagnostic Nuclear Medicines Revenue by Country (2021-2026) & (USD Million)
Table 108. South America Diagnostic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 109. South America Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 110. South America Diagnostic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 111. South America Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 112. Middle East & Africa Diagnostic Nuclear Medicines Sales by Country (2016-2021e) & (K Units)
Table 113. Middle East & Africa Diagnostic Nuclear Medicines Sales by Country (2021-2026) & (K Units)
Table 114. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2016-2021e) & (USD Million)
Table 115. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2021-2026) & (USD Million)
Table 116. Middle East & Africa Diagnostic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 117. Middle East & Africa Diagnostic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 118. Middle East & Africa Diagnostic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 119. Middle East & Africa Diagnostic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Diagnostic Nuclear Medicines Typical Distributors
Table 123. Diagnostic Nuclear Medicines Typical Customers
List of Figures
Figure 1. Diagnostic Nuclear Medicines Picture
Figure 2. Global Diagnostic Nuclear Medicines Sales Market Share by Type in 2020
Figure 3. Tc-99m
Figure 4. F-18
Figure 5. Other
Figure 6. Global Diagnostic Nuclear Medicines Sales Market Share by Application in 2020
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Other
Figure 10. Global Diagnostic Nuclear Medicines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Diagnostic Nuclear Medicines Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Diagnostic Nuclear Medicines Sales (2016-2026) & (K Units)
Figure 32. Global Diagnostic Nuclear Medicines Production Capacity (2016-2026) & (K Units)
Figure 33. Global Diagnostic Nuclear Medicines Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Diagnostic Nuclear Medicines Market Drivers
Figure 35. Diagnostic Nuclear Medicines Market Restraints
Figure 36. Diagnostic Nuclear Medicines Market Trends
Figure 37. Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturer in 2020
Figure 38. Global Diagnostic Nuclear Medicines Revenue Market Share by Manufacturer in 2020
Figure 39. Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Diagnostic Nuclear Medicines Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Diagnostic Nuclear Medicines Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2016-2026)
Figure 43. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2016-2026)
Figure 44. North America Diagnostic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 45. Europe Diagnostic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Diagnostic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 47. South America Diagnostic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Diagnostic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 49. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 50. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2016-2026)
Figure 51. Global Diagnostic Nuclear Medicines Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 53. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2016-2026)
Figure 54. Global Diagnostic Nuclear Medicines Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Diagnostic Nuclear Medicines Sales Market Share by Country (2016-2026)
Figure 56. North America Diagnostic Nuclear Medicines Revenue Market Share by Country (2016-2026)
Figure 57. North America Diagnostic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 58. North America Diagnostic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 59. Europe Diagnostic Nuclear Medicines Sales Market Share by Country (2016-2026)
Figure 60. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country (2016-2026)
Figure 61. Europe Diagnostic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 62. Europe Diagnostic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Diagnostic Nuclear Medicines Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 67. South America Diagnostic Nuclear Medicines Sales Market Share by Country (2016-2026)
Figure 68. South America Diagnostic Nuclear Medicines Revenue Market Share by Country (2016-2026)
Figure 69. South America Diagnostic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 70. South America Diagnostic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Diagnostic Nuclear Medicines Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の核医学用機器市場 2021：企業別、地域別、種類・用途別 The Nuclear Medicine Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…- 世界の排卵誘発薬市場 2021：企業別、地域別、種類・用途別 The Fertility Medicines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 核心臓学の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular di…
- 腫瘍学におけるコンパニオン診断テストの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer. Scope of the Report: This re…
- 世界の麻酔薬市場 2021：企業別、地域別、種類・用途別 The Anaesthetic Medicines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…